1. W.I. Khalife, Y.D. Tang, J.A. Kuzman, T.A. Thomas, B.E. Anderson, S. Said, P. Tille, E.H. Schlenker, A.M. Gerdes, Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am. J. Physiol. 289(6), H2409–H2415 (2005). doi: 10.1152/ajpheart.00483.2005
2. N. Rodondi, D.C. Bauer, A.R. Cappola, J. Cornuz, J. Robbins, L.P. Fried, P.W. Ladenson, E. Vittinghoff, J.S. Gottdiener, A.B. Newman, Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J. Am. Coll. Cardiol. 52(14), 1152–1159 (2008). doi: 10.1016/j.jacc.2008.07.009
3. N. Rodondi, A.B. Newman, E. Vittinghoff, N. de Rekeneire, S. Satterfield, T.B. Harris, D.C. Bauer, Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch. Intern. Med. 165(21), 2460–2466 (2005). doi: 10.1001/archinte.165.21.2460
4. M.D. Danese, P.W. Ladenson, C.L. Meinert, N.R. Powe, Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J. Clin. Endocrinol. Metab. 85(9), 2993–3001 (2000)
5. A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 132(4), 270–278 (2000)